Bosh sahifa524494 • BOM
add
IPCA Laboratories Ltd
Yopilish kursi
1 573,20 ₹
Kunlik diapazon
1 568,25 ₹ - 1 597,80 ₹
Yillik diapazon
1 042,00 ₹ - 1 708,70 ₹
Bozor kapitalizatsiyasi
403,73 mlrd INR
Oʻrtacha hajm
10,87 ming
Narx/foyda
61,03
Dividend daromadliligi
0,25%
Asosiy maydon
NSE
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (INR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 23,55 mlrd | 15,78% |
Joriy xarajat | 12,55 mlrd | 11,53% |
Sof foyda | 2,29 mlrd | 58,20% |
Sof foyda marjasi | 9,74 | 36,61% |
Har bir ulushga tushum | 9,05 | 58,22% |
EBITDA | 4,41 mlrd | 41,84% |
Amaldagi soliq stavkasi | 28,80% | — |
Balans
Jami aktivlari
Jami passivlari
| (INR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 9,03 mlrd | -3,30% |
Jami aktivlari | 114,24 mlrd | 0,35% |
Jami passivlari | 33,06 mlrd | -13,52% |
Umumiy kapital | 81,18 mlrd | — |
Tarqatilgan aksiyalar | 253,57 mln | — |
Narxi/balansdagi bahosi | 5,95 | — |
Aktivlardan daromad | — | — |
Kapitaldan daromad | 9,23% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (INR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 2,29 mlrd | 58,20% |
Operatsiyalardan naqd pul | — | — |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | — | — |
Boʻsh pul | — | — |
Haqida
Ipca Laboratories Limited is an Indian multinational pharmaceutical company based in Mumbai. It produces theobromine, acetylthiophene, and p-bromotoluene as active pharmaceutical ingredients. Ipca sells these APIs and their intermediates globally. It produces more than 150 formulations that include oral liquids, tablets, dry powders, and capsules. Wikipedia
Tashkil etilgan
19-okt, 1949
Sayt
Xodimlar soni
17 335
